Chargement en cours...
647. Adoption of the updated fluoroquinolones breakpoints for Gram negative bacteria in clinical microbiology laboratories
BACKGROUND: Despite the multiple safety warnings related to fluoroquinolones (FQs) treatment, their use remains unavoidable in several occasions due to their broad spectrum of coverage including activity against multi-drug resistant glucose non-fermenting Gram-negative bacteria such as Pseudomonas s...
Enregistré dans:
| Publié dans: | Open Forum Infect Dis |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7776592/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.841 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|